Recent advances in gene therapy for atrial fibrillation.

J Cardiovasc Electrophysiol

Feinberg Cardiovascular and Renal Research Institute, Northwestern University-Feinberg School of Medicine, Chicago, Illinois, USA.

Published: October 2021

Atrial fibrillation (AF) is the most common heart rhythm disorder in adults and a major cause of stroke. Unfortunately, current treatments for AF are suboptimal as they are not targeting the molecular mechanisms underlying AF. In this regard, gene therapy is emerging as a promising approach for mechanism-based treatment of AF. In this review, we summarize recent advances and challenges in gene therapy for this important cardiovascular disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281901PMC
http://dx.doi.org/10.1111/jce.15116DOI Listing

Publication Analysis

Top Keywords

gene therapy
12
atrial fibrillation
8
advances gene
4
therapy atrial
4
fibrillation atrial
4
fibrillation common
4
common heart
4
heart rhythm
4
rhythm disorder
4
disorder adults
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!